The Centers for Medicare and Medicaid Services approved SPA 20-0014 on July 15, 2020. SPA 20-0014 addresses CSP service delivery limitations during the COVID-19 emergency. For more information read the approved SPA pages. Posted byMatt Westerfield July 16, 2020 0 Share: Related Articles MS SPA 24-0012 Value-Based Drug Rebate submitted to CMS Synagis® 2022 off-season prior authorization form Public Notice for MS SPA 21-0018 Covered Outpatient Drugs SPA 18-0011 Physician Administered Drugs (PAD) approved by CMS MS SPA 20-0015-CHIP submitted to CMS Age prior authorization requirement for tricyclic antidepressants to take effect August 17